Shanghai and Taipei, December 12, 2025 --- Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and TaiGen Biotechnology, a listed discovery-based and market-focused pharmaceutical company, as well as TaiGen Biopharmaceuticals, its wholly-owned Beijing subsidiary (both referred to as “TaiGen”), today announced an exclusive pipeline out-licensing collaboration. 

Lori Lerner, MD, associate professor of urology at Boston University Chobanian & Avedisian School of Medicine, is the recipient of the 2026 Distinguished Contribution Award from the American Urological Association (AUA).

 

Lerner, who also is chief of urology and deputy chief of surgical service at the VA Boston Healthcare System, received this honor for advancing novel surgical technologies and education related to benign prostatic hyperplasia, also known as BPH. Each year, the AUA honors the contributions of physician researchers and educators to the field of medicine, the specialty of urology, and the AUA.

In a translational study led by the University of Leipzig Medical Center and the Fraunhofer IZI, researchers have examined how two innovative CAR T-cell therapies targeting the B-cell maturation antigen perform in patients with hard-to-treat multiple myeloma. Their aim was to determine which molecular mechanisms influence the therapeutic success of such living, cell-based therapies in this blood cancer. The findings have been published in the renowned journal Cancer Cell. The Leipzig research team led by Professor Maximilian Merz and Dr Kristin Reiche has now secured a further two million euros in funding for a new project to advance the development of next-generation immunotherapies for multiple myeloma.

The German Federal Institute for Risk Assessment (BfR) is working with the Max Rubner Institute (MRI) to investigate the influence of parental nutrition on children's eating habits. To this end, the "kids/family" module of the COPLANT study is being launched in Berlin and Karlsruhe, for which parent-child pairs are currently being sought. COPLANT is the most comprehensive study to date on plant-based nutrition among adults in German-speaking countries. Now, children are also to be included in the study through the new module. The focus of the new part of the study is on researching different diets in families. Whether vegan, vegetarian, pescetarian or mixed diet – nutrition today is more diverse than ever. "We still know little about how plant-based diets of parents affect the eating habits and food consumption of children," says Professor Dr Tanja Schwerdtle, President of the MRI. "The new study module should provide insights into this." There is also a lack of clear scientific data on the health effects: "We want to better understand how a vegan, vegetarian or pescetarian nutrition in a family environment is related to the health of children and adolescents," explains Professor Dr Cornelia Weikert, head of the COPLANT study at the BfR. "That's why we need the support of committed families."